Phage/nanoparticle cocktails for a biocompatible and environmentally friendly antibacterial therapy. [PDF]
Wdowiak M +8 more
europepmc +1 more source
New Viability Assays for Acanthamoeba castellanii Trophozoites and Cysts Allow Rapid Assessment of Drug Activity. [PDF]
Flynn CA +4 more
europepmc +1 more source
Silver(I)-NHC Complexes as Dual-Action Agents Against Pathogenic <i>Acanthamoeba</i> Trophozoites: Anti-Amoebic and Anti-Adhesion Activities. [PDF]
Hkiri S +6 more
europepmc +1 more source
Pleiotropic regulation of bacterial toxin production and Allee effect govern microbial predator-prey interactions. [PDF]
Suma HR, Stallforth P.
europepmc +1 more source
Azole-based compounds as potential anti-<i>Acanthamoeba</i> agents. [PDF]
Qubais Saeed B +5 more
europepmc +1 more source
Evaluating the amoeba thioredoxin reductase selenoprotein as potential drug target for treatment of Acanthamoeba infections. [PDF]
Loufouma-Mbouaka A +6 more
europepmc +1 more source
Inhibitory Effect of a Novel Ophthalmic Solution on <i>Acanthamoeba castellanii</i> Adhesion and Biofilm Formation on Human Corneal Epithelium. [PDF]
D'Oria F +8 more
europepmc +1 more source
Recent in vitro advances in the ocular antimicrobial agents against Acanthamoeba. [PDF]
Chen CH +4 more
europepmc +1 more source
Staurosporine as a Potential Treatment for Acanthamoeba Keratitis Using Mouse Cornea as an Ex Vivo Model. [PDF]
Rodríguez-Expósito RL +9 more
europepmc +1 more source

